Various strategies for developing APOBEC3G protectors to circumvent human immunodeficiency virus type 1

被引：0
|
作者：
Bao, Qiqi [1 ,2 ]
Zhou, Jinming [1 ,2 ]
机构：
[1] Zhejiang Normal Univ, Dept Chem, Key Lab Minist Educ Adv Catalysis Mat, 688 Yingbin Rd, Jinhua 321004, Peoples R China
[2] Zhejiang Normal Univ, Coll Chem & Life Sci, Drug Dev & Innovat Ctr, 688 Yingbin Rd, Jinhua 321004, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 250卷
关键词：
HIV-1; REVERSE-TRANSCRIPTASE; SMALL-MOLECULE INHIBITION; CYTIDINE DEAMINASE; MESSENGER-RNA; ANTIRETROVIRAL THERAPY; ANTIVIRAL ACTIVITY; CBF-BETA; INDEPENDENT RESTRICTION; ENZYME APOBEC3G; INNATE IMMUNITY;
D O I：
10.1016/j.ejmech.2023.115188
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Host restriction factor APOBEC3G (A3G) efficiently restricts Vif-deficient HIV-1 by being packaged with progeny virions and causing the G to A mutation during HIV-1 viral DNA synthesis as the progeny virus infects new cells. HIV-1 expresses Vif protein to resist the activity of A3G by mediating A3G degradation. This process requires the self-association of Vif in concert with A3G proteins, protein chaperones, and factors of the ubiquitination ma-chinery, which are potential targets to discover novel anti-HIV drugs. This review will describe compounds that have been reported so far to inhibit viral replication of HIV-1 by protecting A3G from Vif-mediated degradation.
引用
收藏
页数：14
相关论文
共 50 条
  • [1] APOBEC3G incorporation into human immunodeficiency virus type 1 particles
    Zennou, W
    Perez-Caballero, D
    Göttlinger, H
    Bieniasz, PD
    JOURNAL OF VIROLOGY, 2004, 78 (21) : 12058 - 12061
  • [2] APOBEC3G Complexes Decrease Human Immunodeficiency Virus Type 1 Production
    Martin, Kenneth L.
    Johnson, Megan
    D'Aquila, Richard T.
    JOURNAL OF VIROLOGY, 2011, 85 (18) : 9314 - 9326
  • [3] Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1
    Miyagij, Eri
    Opi, Sandrine
    Takeuchi, Hiroaki
    Khan, Mohammad
    Goila-Gaur, Ritu
    Kao, Sandra
    Strebel, Klaus
    JOURNAL OF VIROLOGY, 2007, 81 (24) : 13346 - 13353
  • [4] Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 vif and inhibitors of Vif-APOBEC3G binding
    Mehle, Andrew
    Wilson, Heather
    Zhang, Chengsheng
    Brazier, Andrew Jay
    McPike, Mark
    Pery, Erez
    Gabuzda, Dana
    JOURNAL OF VIROLOGY, 2007, 81 (23) : 13235 - 13241
  • [5] Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes
    Khan, MA
    Kao, S
    Miyagi, E
    Takeuchi, H
    Goila-Gaur, R
    Opi, S
    Gipson, CL
    Parslow, TG
    Ly, H
    Strebel, K
    JOURNAL OF VIROLOGY, 2005, 79 (09) : 5870 - 5874
  • [6] Differential Sensitivity of "Old" versus "New" APOBEC3G to Human Immunodeficiency Virus Type 1 Vif
    Goila-Gaur, Ritu
    Khan, Mohammad A.
    Miyagi, Eri
    Strebel, Klaus
    JOURNAL OF VIROLOGY, 2009, 83 (02) : 1156 - 1160
  • [7] Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F
    Ulenga, Nzovu K.
    Sarr, Abdoulaye Dieng
    Thakore-Meloni, Seema
    Sankale, Jean-Louis
    Eisen, Geoff
    Kanki, Phyllis J.
    JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (04): : 486 - 492
  • [8] Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif
    Kao, Sandra
    Goila-Gaur, Ritu
    Miyagi, Eri
    Khan, Mohammad A.
    Opi, Sandrine
    Takeuchi, Hiroaki
    Strebel, Klaus
    VIROLOGY, 2007, 369 (02) : 329 - 339
  • [9] Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F
    Russell, Rebecca A.
    Pathak, Vinay K.
    JOURNAL OF VIROLOGY, 2007, 81 (15) : 8201 - 8210
  • [10] Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging
    Luo, K
    Liu, BD
    Xiao, ZX
    Yu, YK
    Yu, XH
    Gorelick, R
    Yu, XF
    JOURNAL OF VIROLOGY, 2004, 78 (21) : 11841 - 11852
12345